Outcomes after Adjuvant Therapy in High-Intermediate and High-risk Early-stage Uterine Carcinoma

被引：0
|
作者：
Tatebe, K. [1 ]
Hasan, Y. [1 ]
Son, C. H. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1775
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TU_21_3527
引用
收藏
页码：E654 / E654
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma
    Stahl, John M.
    Damast, Shari
    Bledsoe, Trevor J.
    An, Yi
    Verma, Vivek
    Yu, James B.
    Young, Melissa R.
    Lester-Coll, Nataniel H.
    BRACHYTHERAPY, 2018, 17 (02) : 399 - 406
  • [42] Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate Risk Stage I Endometrial Cancer
    Pollock, Ariel
    McGunigal, Mary
    Doucette, John T.
    Liu, Jerry
    Chadha, Manjeet
    Kalir, Tamara
    Gupta, Vishal
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E27 - E27
  • [43] Chemotherapy for high-risk early-stage endometrial cancer
    Kodama, Junichi
    Seki, Noriko
    Hiramatsu, Yuji
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (01) : 42 - 47
  • [44] Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer
    Cao, Lijie
    Wen, Hao
    Feng, Zheng
    Han, Xiaotian
    Zhu, Jun
    Wu, Xiaohua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 52 - 58
  • [45] ENDOMETRIAL CANCER - THE HIGH-RISK EARLY-STAGE PATIENT
    MORROW, CP
    WESTERN JOURNAL OF MEDICINE, 1990, 153 (01): : 78 - 79
  • [46] Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma
    Hamilton, CA
    Liou, WS
    Osann, K
    Berman, ML
    Husain, A
    Teng, NN
    Kapp, DS
    Chan, JK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03): : 839 - 844
  • [47] Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
    Tate, Keisei
    Yoshida, Hiroshi
    Ishikawa, Mitsuya
    Uehara, Takashi
    Ikeda, Shun-ichi
    Hiraoka, Nobuyoshi
    Kato, Tomoyasu
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (03)
  • [48] A comparison of adjuvant therapy approaches for patients with early-stage uterine serous carcinoma.
    Kurnit, Katherine
    Nobre, Silvana Pedra
    Fellman, Bryan M.
    Iglesias, David A.
    Lindemann, Kristina
    Eriksson, Ane Gerda Zahl
    Atasevan, Beyhan
    Glaser, Gretchen Elizabeth
    Mueller, Jennifer Jean
    Soliman, Pamela T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Adjuvant therapy for women with high-risk endometrial carcinoma
    Dowdy, Sean C.
    Glaser, Gretchen E.
    LANCET ONCOLOGY, 2018, 19 (03): : 268 - 269
  • [50] Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort
    Farrell, Rhonda
    Dixon, Suzanne C.
    Carter, Jonathan
    Webb, Penny M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (07) : 1379 - 1386
12345